ADARx Pharmaceuticals Raises $446.3 Million in Upsized US IPO
ADARx Pharmaceuticals raised $446.3 million in an upsized US initial public offering, pricing 26.3 million shares at $17 each, the top end of its marketed range. The San Diego-based biotech had initially planned to...